The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer (NSCLC) or pancreatic cancer. The drug is the first comprehensive ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...

Oncopeptides had been hoping that the results of its confirmatory OCEAN trial would be enough to sway the panel on the peptide-drug conjugate, which was granted accelerated approval for this ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.The medicine, part of the class known as GLP-1 ...

the FDA received 1,516 requests for this designation, and only 587 have been granted. This is in line with previous years, during which around 30-40% of requests have been approved. Dostarlimab ...

The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed with a rare cardiovascular disease, transthyretin amyloid ...

On Wednesday, the FDA approved Merus N.V.’s (NASDAQ:MRUS) Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or non–small cell ...

MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight ...

This vintage rug sets the tone for a life well lived. It features a printed repeat medallion design in ivory, grey, and latte brown multicolor. Flat woven from a supersoft, machine washable blend of ...

Alert FDA OKs Novel Levodopa-Based Regimen for Parkinson’s Vyalev (AbbVie) is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy to address motor fluctuations ...

The company’s roots are in the medical field, and it has previously stated its goal of securing FDA approval for all metrics on its smart ring. The Movano Evie had a tough start with ...